InvestorsHub Logo
Followers 399
Posts 86393
Boards Moderated 2
Alias Born 02/05/2004

Re: jerzybondon post# 402368

Monday, 03/26/2018 1:55:12 PM

Monday, March 26, 2018 1:55:12 PM

Post# of 647938
Yes correct. Again I do not care what they do in the short term. I think both of these names have growth. Hell look at CPRX they trade at 1X annual earnings for Firdapse and that is only on the LEMS application. That does not include CMS or myasthenia gravis. They have 80 million in cash and no debt. Should submit their NDA any day now IMO. Approval and this one goes much higher. Hell the best part about it is that the drug is already being given out to patience it just does not have an approval by the FDA yet. But CPRX is looking like they could get it and that will make them the exclusive supplier of the drug for 7 years. Being its already being given out they will not have to put a bunch of time and money into selling it.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.